Pharmacologic and therapeutic features of sulbutiamine

Drugs of Today

Volumn 35, Issue 3, 1999, Pages 187-192

  Van Reeth, Olivier ^a,b,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

SULBUTIAMINE;

ASTHENIA; CIRCADIAN RHYTHM; COGNITION; DRUG ELIMINATION; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; MEMORY; REVIEW; SLEEP WAKING CYCLE; TREATMENT INDICATION;

EID: 0032957863     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.3.533848     Document Type: Review

References (32)

1. Watanabe, S., Bruera, E. Anorexia and cachexia, asthenia, and lethargy. Hematol Oncol Clin North Am 1996, 10: 189-206.
2. Piper, B.F. Fatigue. In: Pathophysiology Phenomena in Nursing: Human Response to Illness. Carrieri, V.K., Lindsey, A.M., West, C.M. (Eds.). W.B. Saunders: Philadelphia 1986, 219-34.
3. Feuerstein, C. Neurophysiological data concerning fatigue. Role of the reticular activating system. Entretiens de Bichat 1992, Suppl.: 11-9.
4. Adams, R. Anxiety, depression, asthenia and personality disorders. In: Harrison's Principles of Internal Medicine. Petersdorf, R., Adams, R., Braunwald, E. (Eds.). McGraw Hill: New York 1983, 68-75.
5. Aaronson, N.K., Ahmedzai, S., Bergman, B. et al. The European organization for research and treatment of cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85: 365-76.
6. Smets, E.M.A., Garssen, B., Bonke, B., de Haes, C.J.M. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39: 315-25.
7. Piper, B.F., Lindsey, A.M., Dodd, M.J. The development of an instrument to measure the subjective dimension of fatigue. In: Key Aspects of Comfort. Management of Pain, Fatigue and Nausea. Funck, S.G., Tornquist, E.M., Campagne, M.T. (Eds.). Springer: New York 1989, 219-34.
8. Jouquan, J. La sulbutiamine dans l'asthénie: 60 à 90% de succès selon les manifestations, lesquelles choisir? CR Ther Pharmacol Clin 1985, 4: 1-4.
9. Du Boistesselin, R., Hum, M. Etude histochimique de l'imprégnation des formations cérébrales après administration de sulbutiamine. Synth Med 1985, 309: 11-2.
10. Mesulam, M.M., Mufson, E.J., Wainer, B.H., Levey, A. I. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 1983, 10: 1185-201.
11. Micheau, J., Durkin, T.P., Destrade, T.P., Rolland, Y., Jaffard, R. Chronic administration of sulbutiamine improves long term memory formation in mice: Possible cholinergic formation. Pharmacol Biochem Behav 1985, 23: 195-8.
12. Poignant, J.C. Possiblité d'intervention d'Arcalion 200 sur la biosynthèse de la sérotonine. Med Prat 1979, Suppl. 3.
13. Yoshimura, K., Nishibe, Y., Inoue, Y., Hirono, S., Toyoshima, K. Animal experiments on thiamine avitaminosis and cerebral function. J Nutr Sci Vitaminol 1976, 22: 429-37.
14. Onodera, K., Sakurada, S., Ando, R. et al. The effect of thiamine deficiency on the actions of drugs affecting the central nervous system in rats. Nippon Yakurigaku Zasshi 1980, 76: 109-15.
15. Balzamo, E., Vuillon-Cacciutolo, G. Facilitation de l'état de veille d'un traitement semi-chronique par la sulbutiamine chez Macaca mulata. Rev EEG Neurophysiol Clin 1982, 12: 373-8.
16. Turek, F.W., Van Reeth, O. Circadian rhythms. In: Handbook of Physiology. Fregly, M.J., Blatteis, C.M. (Eds.). Oxford Univ. Press: Oxford 1995, 1329-59.
17. Van Reeth, O., Sturis, J., Byrne, M.M. et al. Nocturnal exercise phase delays the circadian rhythms of melatonin and thyrotropin secretion in normal men. Am J Physiol 1994, 266: E964-74.
18. Van Reeth, O., Turek, F.W. Stimulated activity mediates phase shifts in the hamster circadian clock induced by dark pulses or benzodiazepines. Nature 1989, 339: 49-51.
19. Consoli, S., Mas, M. Study of a multivalent antifatigue agent, Arcalion 200, on alertness and stress in high level competitive sports. Psychol Med 1988, 20: 249-57.
20. Israel, L., Del'Accio, E., Hugonot, R. Value of Arcalion 200 in elderly astheniec patients. J Med Prat 1989, 3: 19-24.
21. Van Reeth, O., Zhang, Y., Zee, P.C., Turek, F.W. Aging alters the feedback effects of the activity-rest cycle on the circadian clock. Am J Physiol 1992, 263: R981-6.
22. Van Reeth, O., Zhang, Y., Zee, P.C., Turek, F.W. The effects of aging on the entraining properties of activity-inducing stimuli on the circadian clock. Brain Res 1993, 607: 286-92.
23. Van Reeth, O., Zhang, Y., Zee, P.C., Turek, F.W. Grafting fetal suprachiasmatic nuclei in the hypothalamus of old hamsters restores the feedback effects of the activity-rest cycle on the circadian clock. Brain Res 1994, 643: 338-42.
24. Van Reeth, O., Zhang, Y., Lesourd, M., Dard Brunelle, B., Zee P.C., Turek, F.W. Age related changes in the hamster's circadian system partially reversed by treatment with sulbutiamine, a vit B-1 related compound. Biol Rhythm Res 1994, 25: 477-9.
25. Gallo, C. Ethological studies of the effects of sulbutiamine on operant behavior in rats. 3rd Int Cong Neuroethol (McGill Univ, Montreal) Aug 1992.
26. S-5007. Brochure for investigators. Servier 1990.
27. Achard, J. A versatile approach to the treatment of post-infectious asthenia: Arcalion 200. CR Ther Pharmacol Clin 1985, 4: 23-7.
28. Krueger, J.M., Majde, J.A. Sleep as a host defense: Its regulation by microbial products and cytokines. Clin Immunol Immunopharmacol 1990, 57: 188-99.
29. Israel, L., Nathan, C. Etude en double aveugle d'Arcalion 200 sur les troubles de la mémoire des patients âgés asthéniques. Psychol Med 1988, 20: 1525-31.
30. Valverde Acuña, V. Utilisation de la sulbutiamine chez un groupe d'étudiants universitaires présenant un syndrome de fatigue psycho-somatique. Gaz Med 1985, 92: 1-3.
31. Balestreri, R., Bertolini, S. Etude de l'activité thérapeutique d'Arcalion 200 sur les manifestations psycho-physiques des syndromes astheniques. Vie Med 1981, 18.
32. Waynberg, J. When should Arcalion 200 be prescribed? JAMA 1991, 222: 4-12.